COMMUNIQUÉS West-GlobeNewswire

Spectral Announces Second Quarter Results
15/08/2019
TORONTO, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]
Inspire Medical Systems, Inc. Announces Additional 17.7 Million Covered Lives with Seven New Coverage Policies
15/08/2019
Includes Positive Policy from Health Care Service Corporation, the Largest Customer-Owned Health Insurer in the U.S. and Fourth Largest Overall MINNEAPOLIS, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc [...]
WishBone Medical Adds Resorbable Implants to Product Offerings
15/08/2019
WishBone Medical Gains Distribution Rights to OsteoCrete® WARSAW, Ind., Aug. 15, 2019 (GLOBE NEWSWIRE) -- WishBone Medical announces a private label distribution agreement with Bone Solutions, Inc. (BSI) for worldwide [...]
HealthLynked Reports Record Revenue Growth in 2nd Quarter 2019
15/08/2019
Revenue growth of 113% to $1.2 million Net Loss reduction of $230,675 or 21% NAPLES, Fla., Aug. 15, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK ), a provider of healthcare-related technology that connects [...]
Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update
15/08/2019
Ultragenyx Pharmaceutical, Inc. expands collaboration, becoming Arcturus’ largest shareholder Cystic Fibrosis Foundation increases commitment to $15 million Arcturus receives Orphan Drug Designation from the U.S. FDA [...]
Micron Solutions, Inc. Reports 2019 Second Quarter Results
15/08/2019
FITCHBURG, Mass., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
Auris Medical Provides Business Update and Reports First Half 2019 Financial Results
15/08/2019
Hamilton, Bermuda, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Enrollment of first patient in TRAVERS Phase 2 trial with AM-125 in acute vertigo Enrollment completed in Phase 1b trial with AM-201 in antipsychotic-induced weight [...]
Bio-Path Holdings Reports Second Quarter 2019 Financial Results
15/08/2019
Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi [...]
Hemispherx Issues 2019 Second Quarter Report Citing Strong Steady Progress in Cancer Clinical Trials
15/08/2019
OCALA, Fla., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and [...]
3B Medical Announces Entry on the Inc 5000 List of America’s Fastest Growing Companies
15/08/2019
NEW YORK, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Inc. magazine today revealed that 3B Medical joined the Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a [...]
Carey Hart + Next Green Wave Launching Premium Wellness CBD Brand ‘HartLuck’
15/08/2019
The “Fix Yourself” Line Of Products Is Now Available For Sale Direct To Consumer, Distributed From Our SDC Brand House VANCOUVER, British Columbia, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Next Green Wave Holdings Inc. (CSE: [...]
BioPorto Announces Q2 2019 Report
15/08/2019
August 15, 2019 Announcement no. 15 Q2 2019 Report Highlights Additional Information request from FDA on the pediatric application for The NGAL Test™ postpones clearance In mid-July 2019, BioPorto received an additional [...]
Bavarian Nordic Announces First Half 2019 Results
15/08/2019
COPENHAGEN, Denmark, August 15, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first half of 2019 and releases its financial calendar for [...]
H1 2019: Tecan again posts significant increase in sales, driven by strong growth in the Life Sciences Business
15/08/2019
Financial results for the first half of 2019 Sales of CHF 296.1 million (H1 2018: CHF 273.5 million) Growth of 8.4% in local currencies or 8.3% in Swiss francs Organic growth of 6.3% in local currencies Strong growth in [...]
CorMedix Inc. Announces Exchange Agreement With Its Largest Investor
15/08/2019
BERKELEY HEIGHTS, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
NRC Health Announces Second-Annual Consumer Loyalty Awards Winners
15/08/2019
U.S. healthcare organizations earned the national honor by achieving 75th percentile scores across seven aspects of consumer loyalty LINCOLN, Neb., Aug. 14, 2019 (GLOBE NEWSWIRE) -- NRC Health , the leading provider of [...]
Seelos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15/08/2019
NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, announced today that it has granted a stock option to purchase 97,285 shares of common [...]
Exactus, Inc. Reports Second Quarter 2019 Results
14/08/2019
2019 Highlights January 2019 - Entered into the hemp-derived CBD market January 2019 - Entered into Development and Supply Agreement with Ceed2Med March 2019 - Placed a $1 million purchase order with Ceed2Med March 2019 [...]
Ascendis Pharma A/S Announces Second Quarter 2019 Financial Results and Business Update Conference Call on August 28
14/08/2019
COPENHAGEN, Denmark, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced [...]

Pages